georgejjl
14 minutes ago
"...Looking ahead, Anavex plans to present its ATTENTION-AD trial findings at the 2025 AD/PD™ Conference and expand its clinical development programs to Phase III and IV trials.
“Our vision is to one day provide patients with therapies that are effective, accessible, and transformativ